Cognitive Behavior Therapy for Type 2 Diabetes Patients: Results of a Pilot Study with the Structured Program DaVinci Diabetes®

被引:3
|
作者
Martin, S. [1 ]
Kempf, K. [1 ]
Dirk, M. [1 ]
Kolb, H. [2 ]
Hebestreit, A. [3 ]
Bittner, G. [3 ]
机构
[1] Sana Klinikum Dusseldorf GmbH, W Deutsch Diabet & Gesundheitszentrum, Sana Krankenhaus Gerresheim, D-40625 Dusseldorf, Germany
[2] Hagedorn Res Inst, Gentofte, Denmark
[3] Deutsch Zentrum Mentale Med & Mentness, Essen, Germany
关键词
Type; 2; diabetes; lifestyle change; cognitive behaviour therapy; motivation; HbA1c; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; SELF-MANAGEMENT; TRIAL; PREVENTION; REDUCTION; MELLITUS; INSULIN; PEOPLE; METFORMIN;
D O I
10.1055/s-0029-1224686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Information about lifestyle changes with healthy diet and physical activity are included in diabetes education programs although implication into daily routine is rarely successful. Therefore, a structured program for cognitive behaviour therapy (DaVinci Diabetes (R)) without diabetes specific topics was developed and evaluated in a pilot study. Using an interactive computer program, patients with type 2 diabetes (T2DM) performed guided cognitive behaviour therapy for 3 months. Glucometabolic control was analyzed before and after the program as well as after 12 months. Via the program all participants (n=19) identified grievances in their lifestyle and attitude and appropriately implemented lifestyle changes autonomously. This resulted in significant reductions of weight, BMI, waist circumference and triglyceride levels after 3 months, which further improved during the 12 months of follow-up. Mean HbA1c, which already was <7.0% at baseline, became reduced by 0.48% during the program and still remained below base level after 12 months. Percentage of participants with an HbA1c <6.5% increased from 21% at baseline to 37% after 12 months. Cognitive behaviour therapy is a new approach to achieve sustained improvements of risk factors for diabetic complications in persons with type 2 diabetes.
引用
收藏
页码:370 / 373
页数:4
相关论文
共 50 条
  • [21] Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study
    Vasandani, Chandna
    Clark, Gregory O.
    Adams-Huet, Beverley
    Quittner, Claudia
    Garg, Abhimanyu
    DIABETES CARE, 2017, 40 (05) : 694 - 697
  • [22] Combination statin and fibrate therapy in type 2 diabetes: Results from the lipids in diabetes study
    Neil, A
    Wheeler, F
    Cull, C
    Manley, S
    Keenan, J
    Holman, R
    DIABETES, 2003, 52 : A74 - A74
  • [23] Serum and salivary adipokines in type 2 diabetes - Results of a pilot study in India
    Vinitha, Ramachandran
    Yogalakshmi, Raghuraman
    Rajeswari, Anandhan
    Snehalatha, Chamukuttan
    Nair, Dhruv Rajesh
    Susairaj, Priscilla
    Satheesh, Krishnamoorthy
    Nanditha, Arun
    Raghavan, Arun
    Arun, K., V
    Ramachandran, Ambady
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (07)
  • [24] Preventing type 2 diabetes in high risk teens: Results of a pilot study
    Grey, M
    Berry, D
    Davidson, M
    Galasso, P
    Melkus, G
    Peckham, L
    Gustafson, E
    DIABETES, 2002, 51 : A16 - A16
  • [25] Cognitive dysfunction in patients with type 2 diabetes
    Reijmer, Yael D.
    van den Berg, Esther
    Ruis, Carla
    Kappelle, L. Jaap
    Biessels, Geert Jan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 507 - 519
  • [26] A structured education programme for patients with Type 2 diabetes
    Livingstone, R.
    Smith, C.
    DIABETIC MEDICINE, 2017, 34 : 126 - 126
  • [27] Effect of liraglutide on lipids in patients with type 2 diabetes: a pilot study
    Aoki, Kazutaka
    Kamiyama, Hiroshi
    Takihata, Masahiro
    Taguri, Masataka
    Shibata, Eriko
    Shinoda, Kazuaki
    Yoshii, Taishi
    Nakajima, Shigeru
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2020, 67 (09) : 957 - 962
  • [28] Effects of clinical audit on the quality of care in patients with type 2 diabetes: Results of the DIABEST pilot study
    Varroud-Vial, M
    Charpentier, G
    Vaur, L
    Attali, JR
    Balarac, N
    Cervantes, P
    Kleinebreil, L
    Levy-Marchal, C
    Preiss, P
    Weisselberg, C
    Eschwege, E
    DIABETES & METABOLISM, 2001, 27 (06) : 666 - 674
  • [29] Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -: Results of a pilot study
    Parhofer, KG
    Otto, C
    Geiss, HC
    Laubach, E
    Göke, B
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (01) : 49 - 52
  • [30] Improved glycemic control after diabetes education and chromium picolinate/biotin supplementation in type 2 diabetes: results from patients experience pilot program
    Juturu, V
    Ruelle, A
    Hudson, MS
    Komorowski, JR
    TRACE ELEMENTS AND ELECTROLYTES, 2006, 23 (01) : 66 - 72